Suc-Ile-Glu(gama-pip)-Gly-Arg-pNA.HCl

Suc-Ile-Glu(gama-pip)-Gly-Arg-pNA.HCl is a colorimetric substrate for Factor Xa.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Suc-Ile-Glu(gama-pip)-Gly-Arg-pNA.HCl(CAS 1379822-04-4)

CAT No: 10-101-350

CAS No:1379822-04-4

Synonyms/Alias:1379822-04-4;N-(3-carboxy-1-oxopropyl)-L-isoleucyl-5-oxo-5-(1-piperidinyl)-L-norvalylglycyl-N-(4-nitrophenyl)-L-argininamide, monohydrochloride;4-[[(2S,3S)-1-[[(2S)-1-[[2-[[(2S)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxo-5-piperidin-1-ylpentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid;hydrochloride;Suc-Ile-Glu(|A-pip)-Gly-Arg-pNA (hydrochloride);Suc-Ile-Glu(gamma-pip)-Gly-Arg-pNA (hydrochloride);HY-P3126;AKOS040756705;DA-78084;MS-31469;PD126664;CS-0146537;G18143;Suc-Ile-Glu(??-pip)-Gly-Arg-pNA hydrochloride;SUC-ILE-GLU(GAMMA-PIP)-GLY-ARG-PNA HYDROCHLORIDE;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C34H53ClN10O10
M.W/Mr.
797.3

Suc-Ile-Glu(gama-pip)-Gly-Arg-pNA.HCl, also known as a chromogenic peptide substrate, is a synthetic peptide designed for the sensitive detection and quantitative analysis of specific serine protease activities. Characterized by its tailored amino acid sequence and the incorporation of a para-nitroanilide (pNA) chromophore, this compound enables precise monitoring of enzymatic cleavage events. The presence of the succinyl group at the N-terminus and the gamma-piperidide modification on the glutamic acid residue further enhance its selectivity and stability, making it an invaluable tool in biochemical research focused on protease specificity, enzyme kinetics, and inhibitor screening.

Enzyme Activity Assays: Utilized extensively as a substrate in chromogenic enzyme assays, this peptide enables researchers to quantitatively assess the activity of target serine proteases. Upon proteolytic cleavage at the specific peptide bond, the release of the pNA moiety generates a measurable yellow color, which can be detected spectrophotometrically. This property facilitates high-throughput screening and kinetic analysis, providing critical data on enzyme catalytic efficiency, substrate preference, and optimal assay conditions.

Protease Specificity Studies: The defined sequence and structural modifications of this substrate allow for detailed investigation of protease substrate recognition. By employing the compound in comparative assays with related enzymes or mutant variants, scientists can elucidate the determinants of protease specificity and map substrate-binding sites. This approach supports rational enzyme engineering and the design of selective inhibitors by revealing key amino acid interactions involved in catalysis.

Inhibitor Screening: The chromogenic properties of this peptide substrate make it particularly suitable for screening potential protease inhibitors. By monitoring changes in absorbance linked to pNA release, researchers can rapidly evaluate the efficacy of small molecules or biological inhibitors in real time. Such assays are essential in the early stages of drug discovery, enabling the identification and optimization of lead compounds that modulate protease activity in a controlled biochemical environment.

Quality Control in Enzyme Production: In industrial and research settings, the compound serves as a reliable reagent for quality control of protease preparations. Its use in standardized activity assays ensures batch-to-batch consistency, verifies enzyme potency, and detects potential contaminants or degradation products. This application is critical for manufacturers and laboratories that require precise enzymatic profiles for downstream applications, such as protein processing or analytical workflows.

Fundamental Mechanistic Research: The substrate's modular peptide structure, combined with its chromogenic readout, provides a versatile platform for probing fundamental aspects of proteolytic mechanisms. Researchers leverage it to dissect the influence of sequence context, post-translational modifications, and environmental factors on enzyme function. These insights contribute to a deeper understanding of protease biology and support the development of advanced biochemical tools for the study of protein turnover, signaling cascades, and regulatory networks.

InChI
InChI=1S/C34H52N10O10.ClH/c1-3-21(2)30(42-26(45)14-16-29(48)49)33(52)41-25(13-15-28(47)43-18-5-4-6-19-43)31(50)38-20-27(46)40-24(8-7-17-37-34(35)36)32(51)39-22-9-11-23(12-10-22)44(53)54;/h9-12,21,24-25,30H,3-8,13-20H2,1-2H3,(H,38,50)(H,39,51)(H,40,46)(H,41,52)(H,42,45)(H,48,49)(H4,35,36,37);1H/t21-,24-,25-,30-;/m0./s1
InChI Key
UDIBETPIWZURPW-FTHVRPHQSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicescGMP Peptide ServicePeptide Modification ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Analysis ServicesCustom Conjugation ServicePeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers